in addition to the withdrawal from the sec executed by the

New Post Public Reply Private Reply Replies (1) Message Board
microcaps ears #5798
650
in addition to the withdrawal from the sec executed by the former infetech, as explained by mits, NNLX ha to confront the tradeoffs noted below

btw,the number of shareholders, along with other min requirements, are minimum requirements to join a big board -they dont force a company to do so!

from the last cite you've posted re this subject:

"Consider whether cost avoidance is a legitimate driver. Publicly traded companies spend a lot of time and money maintaining the standards required by the national stock exchanges and the SEC. The costs easily exceed $500,000 per year for even the smallest of the small cap companies, to include annual audits, quarterly reviews, legal fees, audit committee fees, SOX compliance costs, annual registration fees and increased insurance premiums for director and officer liability. Oftentimes, boards find that the incremental costs of the public listing outweigh the benefits. Companies often site cost savings as a significant factor in going dark. Saving precious capital is a legitimate reason, but it has a downside."

big boards cost c 185k/yr just to list

most otc co's have decided they cannot even afford the otc $10k news disclosure surcharge(plus other charges) to list on the otcqb-

thus, in 2014-2015, when otc raised the otcqb listing surcharge to 10k/yr =along w other more restrictive changes, many hundreds to thousands of formerly otcqb co's downlisted to the pinks-leaving only ca 1k co's on the otcqb,whereas there are ca 7000-9000 companies on the pinks

the tradeoff is often whether to go belly up or go dark- paying the few specialized loan shark companies for exorbitant loans is a well known death spiral-which NNLX has wisely avoided

the money NNLX has saved since 2014 etc via its present otc classification has allowed NNLX to survive-another long told me years ago NNLX had looked at the requirements to upgrade or uplist -and the requirements were "44 pages long".

there are other reasons for being dark also- in 2009 a new political leader who decided business must be destroyed -bc "all business is evil" (saw the sympathetic liberal doc on a liberal station myself)- politicized the stock market and its regulatory and semi reg agencies with unprecedented unconstitutional orders
to destroy otc co's (since he discovered big co's had too much legal political and eco clout to destroy)-
so thousands of otc co's had their stock illegally restricted without notice

-barring longs w any size position from selling while brokers, mm's and others shorted the stocks to .0001-an illegal never before seen private/public eminent domain scheme against innocent 3rd party purchasers which destroyed many co's and many longs,costing my best friend his life and i lost scores of thousands also.

due to the political pressure to destroy otc stocks-esp the most defenseless low pennies- otc was -either officially or unofficially- greenlighted to impose many new restrictions,which forced many co's to downlist and prevented other co's from uplisting
see my post on wolv re this

i was in a limited info otc co which had an on the ground breakthrough which resulted in rapidly increasing pps - so otc slapped the kiss of death skull and bones on the co.
I personally called otc to find out why. They said they did so bc they assumed xxxx co was running a large promotion- otc does not allow non-pink current co's to run promos-so without any investigation they just slapped the skull and bones for promotional activity.
Under the then hostile to business political environment otc and reg orgs were reportedly given free reign to do just about anything to restrict otc co's.

nobody knows exactly what constitutes a promo in otc's eyes- esp as the political environment changes- but PR's may be interpreted by otc as a promo at their pleasure.
I wouldnt be surprised if otc sent letters to all non current otc classes re this. That may be a reason, besides costs of PR's, why NNLX doesnt use PR's now.

Its even possible the same rationale applies to reporting financials on a web site --if a co isnt current class or higher.
its the carrot and stick- which sometimes boils down to this- either pay us our self set fees to post at a certain classification according to our rules or we will block you from providing info via other methods via the threat of the skull and bones for promo activity.

I'm greatful otc has created the forum to inform investors and in many cases increase transparency but these political and financial reasons often work against transparency also when many thousands of companies cant afford to upgrade to pink current or uplist to the otcqb etc.

otc is for profit public corp which receives c 40% or more of its revenues from the fees they charge co's for their otc postings-the higher the class -the greater the fees
other reasons why NNLX may not upgrade or up-list at this time-besides the sometimes hefty costs to do so-is the nature of the biotech business -one of the most secretive industries replete with very restrictive NDA's, which no doubt tie NNLX's hands. Even SEC reporting co's filings restrict what info is available due to trade secrets and NDA's.






1

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Treadmill Championship: A New Run Begins

Updated Category News Views 2

A Run Like No Other I’ll bet you’ve heard it all when it comes to races—winding city marathons, grueling ultras with rough terrain, and everything in between. But a world championship on treadmills? Now that's a fresh spin! October 23rd, 2026 is when the RUN X™ World Treadmill Championship kicks off, stretching out across the planet in 400 fitness centres...

Continue Reading
MSG Rangers Joining S&P SmallCap 600: Key Moves

Updated Category News Views 5

MSG Rangers Takes Center Ice—In the Market Here we go—MSG Rangers (NYSE: MSGR) is sliding into the S&P SmallCap 600 like a puck on fresh ice, ready to switch places with Arbor Realty Trust (NYSE: ABR) come October 27. Now, that's not just a game changer for MSGR, but also throws some shuffle onto the board for investors in these organizations. We've got Madison Square...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 3

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Tajín's Chamoy Twist: Spice Up Everyday Treats

Updated Category News Views 5

A New Flavor Adventure Lands on Aisles Alright, folks, nothing quite spices up a mundane snack session like a new sauce from a brand with serious street cred. Tajín's latest brainchild, the Twist Chamoy Sauce, just hit a retailer near you. It's promising to take your tastebuds on a rollercoaster ride—no ticket needed, just a generous pour over whatever munchies you're...

Continue Reading
Lyric Health's Grace: Transforming Virtual Healthcare

Updated Category News Views 9

Grace in the Spotlight: A Game-Changer in Virtual Healthcare If you're tired of healthcare tech making big promises and delivering little, this might pique your interest. Lyric Health has rolled out Grace, a multimodal AI addition to their Virtual Care Operating System. This isn’t your run-of-the-mill chatbot — it’s a blend of proactive health monitoring,...

Continue Reading
Saab Q3 2026: Major Contracts Fuel Impressive Growth

Updated Category News Views 3

Saab's Stellar Q3 Performance If there’s one picture capturing the essence of Saab’s third quarter in 2026, it's one brimming with contracts, cash, and sheer growth. They’re racking up tangible wins left and right, and if you're an investor who loves numbers doing a solid 30.6% high jump, Saab's buzzing red-hot. Key Contracts Putting Saab in the Spotlight The very...

Continue Reading
TTMI Under Scrutiny: Ademi LLP's Fraud Investigation

Updated Category News Views 0

Ademi LLP Puts TTMI in the Spotlight If you blinked, you might have missed it, but TTM Technologies, listed on NASDAQ as TTMI, has taken a nosedive recently—shedding over 25% of its stock value in what’s proving to be a hot mess for its shareholders. The cherry on top? Ademi LLP is rolling up its sleeves for an investigation into what looks like a tangled web of...

Continue Reading
FM's Bold $855M Resilience Credit: A Game Changer

Updated Category News Views 5

Breaking Down the US$855 Million Payout Just when you think you’ve got the insurance landscape figured out, FM spins the wheel with a US$855 million resilience credit, all thanks to its mutual structure and healthy results. Let’s unpack this hefty premium offset, shall we? A Second Year of Solid Savings This isn’t FM’s first rodeo. We're talking about a 10%...

Continue Reading
Country Stars Illuminate Art in Philly, Mississippi

Updated Category News Views 3

A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...

Continue Reading
Wood Coatings Market Set for Sustainable Surge by 2032

Updated Category News Views 1

Riding the Wave of Sustainable Coatings Who'd have thought we'd be chatting about wood coatings making such a splash? Turns out, this unsung hero of the materials world is gearing up for some serious growth, with the market projected to hit a crisp $33.34 billion by 2032. That's a decent jump from where it stands today, and it's all thanks to the shift towards...

Continue Reading

Top 5 Most Recently Viewed Articles

How Nasuni Helps Retail Giants Prepare for the Holiday Rush

Updated Category News Views 35

Nasuni Empowers Major Brands for Holiday Success Household brands are continually enhancing their competitiveness, driving customer growth, and boosting productivity with Nasuni's cutting-edge hybrid cloud solutions. As the holiday season approaches, the demands on retailers increase significantly. Nasuni, an enterprise data platform known for its robust capabilities in...

Continue Reading
JDE Peet’s Grants Shares and Awards to Incentive Plan Participants

Updated Category News Views 192

JDE Peet’s Employee Incentive Plans: Recent Grants and Transfers JDE Peet’s N.V. (EURONEXT: JDEP) has made significant strides in its approach to employee incentives, emphasizing its dedication to valuing its workforce. In a recent announcement, the company outlined its actions regarding share grants as part of its ongoing employee incentive plans. These initiatives...

Continue Reading
Liongard Appoints Brook Lee as VP for Community Growth

Updated Category News Views 329

Liongard Appoints Brook Lee as VP to Enhance MSP Engagement Liongard, a leading name in Attack Surface Management catering to Managed Service Providers (MSPs) and IT Service Providers, is excited to announce the appointment of Brook Lee as its new Vice President of Community and Channel. With more than 15 years of experience within the MSP industry, Brook brings a wealth...

Continue Reading
Celebrating Dr. Rachel L. Ivory's Influence in Education

Updated Category News Views 174

Honoring Dr. Rachel L. Ivory for Her Educational Contributions Featured prominently as a Pinnacle Professional Member, Dr. Rachel L. Ivory stands out for her substantial contributions to the fields of education and literature. Her dedication has led her to be recognized by many for her impactful work, especially in leadership training, publishing, and community...

Continue Reading
Zenocutuzumab Trial Yields Promising Results for Cancer

Updated Category News Views 9

Results Revealed: A Game Changer in Cholangiocarcinoma Treatment Zenocutuzumab is stirring the pot in cancer treatment with some potentially ground-breaking results recently unveiled. Partner Therapeutics, a biotech player with skin in the oncology game, has revealed results from the eNRGy trial. These findings have not only turned heads but also led to U.S. FDA approval...

Continue Reading